Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.

Riordan NH, Morales I, Fernández G, Allen N, Fearnot NE, Leckrone ME, Markovich DJ, Mansfield D, Avila D, Patel AN, Kesari S, Paz Rodriguez J

Open source

DOI
10.1186/s12967-018-1433-7
Published
2018 Mar 9
Container
Journal of translational medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12967-018-1433-7,
  title = {Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.},
  author = {Riordan NH and Morales I and Fernández G and Allen N and Fearnot NE and Leckrone ME and Markovich DJ and Mansfield D and Avila D and Patel AN and Kesari S and Paz Rodriguez J},
  year = {2018},
  journal = {Journal of translational medicine},
  doi = {10.1186/s12967-018-1433-7},
  url = {https://doi.org/10.1186/s12967-018-1433-7}
}

RIS

TY  - JOUR
TI  - Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.
AU  - Riordan NH
AU  - Morales I
AU  - Fernández G
AU  - Allen N
AU  - Fearnot NE
AU  - Leckrone ME
AU  - Markovich DJ
AU  - Mansfield D
AU  - Avila D
AU  - Patel AN
AU  - Kesari S
AU  - Paz Rodriguez J
PY  - 2018
JO  - Journal of translational medicine
DO  - 10.1186/s12967-018-1433-7
UR  - https://doi.org/10.1186/s12967-018-1433-7
ER  - 

APA

NH, R., I, M., G, F., N, A., NE, F., ME, L., DJ, M., D, M., D, A., AN, P., S, K., & J, P. R. (2018). Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.. Journal of translational medicine. https://doi.org/10.1186/s12967-018-1433-7

Source records